Sensitization following LVAD implantation using leucodepleted blood is not due to HLA antibodies

American Journal of Transplantation

Volumn 6, Issue 7, 2006, Pages 1712-1717

  Newell, H ^a   Smith, J D ^a   Rogers, P ^a   Birks, E ^a   Danskine, A J ^a   Fawson, R E ^a   Rose, M L ^b  

^a HAREFIELD HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Antibodies; Heart transplantation; HLA; LVAD; Sensitization

Indexed keywords

ALBUMIN; HLA ANTIBODY; HLA ANTIGEN; IMMUNOGLOBULIN G;

ADULT; ALBUMIN BLOOD LEVEL; ALLOIMMUNITY; ANTIBODY SPECIFICITY; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT SURVIVAL; HEART ASSIST DEVICE; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; IMMUNOREGULATION; LYMPHOCYTOTOXICITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIZATION;

ADULT; ALBUMINS; ANIMALS; ANTIBODIES; CARDIAC SURGICAL PROCEDURES; CATTLE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEART VENTRICLES; HLA ANTIGENS; HUMANS; SURVIVAL RATE;

EID: 33745337547     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01342.x     Document Type: Article

References (19)

1. Quaini E Pavie A Chieco S Mambrito B. The Concerted Action 'Heart' European registry on clinical application of mechanical circulatory support systems: Bridge to transplant. The Registry Scientific Committee. Eur J Cardiothorac Surg 1997 11 : 182 188.
2. Kumpati GS Cook DJ Blackstone EH et al. HLA sensitization in ventricular assist device recipients: Does type of device make a difference? J Thorac Cardiovasc Surg 2004 127 : 1800 1807.
3. Goffinet J St Pierre Schneider B. Preformed anti-human leukocyte antigen antibodies jeopardize cardiac transplantation in patients with a left ventricular assist device. Heart Lung 2002 31 : 122 130 quiz, 131-132.
4. Moazami N Itescu S Williams MR et al. Platelet transfusions are associated with the development of anti-major histocompatibility complex class I antibodies in patients with left ventricular assist support. J Heart Lung Transplant 1998 17 : 876 880.
5. Massad MG Cook DJ Schmitt SK et al. Factors influencing HLA sensitization in implantable LVAD recipients. Ann Thorac Surg 1997 64 : 1120 1125.
6. McKenna DH Jr. Eastlund T Segall M Noreen HJ Park S. HLA alloimmunization in patients requiring ventricular assist device support. J Heart Lung Transplant 2002 21 : 1218 1224.
7. John R Lietz K Schuster M et al. Immunologic sensitization in recipients of left ventricular assist devices. J Thorac Cardiovasc Surg 2003 125 : 578 591.
8. John R Lietz K Burke E et al. Intravenous immunoglobulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device recipients. Circulation 1999 100 ( 19 Suppl II229 II235.
9. Gonzalez-Stawinski GV Atik FA McCarthy PM et al. Early and late rejection and HLA sensitization at the time of heart transplantation in patients bridged with left ventricular assist devices. Transplant Proc 2005 37 : 1349 1351.
10. Stringham JC Bull DA Fuller TC et al. Avoidance of cellular blood product transfusions in LVAD recipients does not prevent HLA allosensitization. J Heart Lung Transplant 1999 18 : 160 165.
11. Pagani FD Dyke DB Wright S Cody R Aaronson KD. Development of anti-major histocompatibility complex class I or II antibodies following left ventricular assist device implantation: Effects on subsequent allograft rejection and survival. J Heart Lung Transplant 2001 20 : 646 653.
12. Claas FH Smeenk RJ Schmidt R van Steenbrugge GJ Eernisse JG. Alloimmunization against the MHC antigens after platelet transfusions is due to contaminating leukocytes in the platelet suspension. Exp Hematol 1981 9 : 84 89.
13. Itescu S John R. Interactions between the recipient immune system and the left ventricular assist device surface: Immunological and clinical implications. Ann Thorac Surg 2003 75 ( 6 Suppl S58 S65.
14. Terasaki PI Bernoco D Park MS Ozturk G Iwaki Y. Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture. Am J Clin Pathol 1978 69 : 103 120.
15. Coppage M Blumberg N Chen L et al. Allosensitization and LVAD: It's in the blood-abrogation of HLA allosensitization by transfusion with leukoreduced, ABO identical blood products. Hum Immunol 2003 64 ( 10 Suppl 1 S44.
16. Schall C Klingman L Cook D Valdez R. Pitfalls and ambiguities in antibody screening in patients with cardiac assist devices: The role of flow PRA beads. Hum Immunol 2005 66 ( Suppl S11.
17. Pires ES Parte PP Meherji PK Khan SA Khole VV. Naturally occurring anti albumin antibodies are responsible for false positivity in diagnosis of autoimmune premature ovarian failure. J Histochem Cytochem 2006 54 : 397 405.
18. Schuster M Kocher A John R et al. B-cell activation and allosensitization after left ventricular assist device implantation is due to T-cell activation and CD40 ligand expression. Hum Immunol 2002 63 : 211 220.
19. Itescu S Ankersmit JH Kocher AA Schuster MD. Immunobiology of left ventricular assist devices. Prog Cardiovasc Dis 2000 43 : 67 80.